曾 堯麟

Medicine & Life Sciences

1. Acids 22%
2. Adenocarcinoma of Lung 20%
3. Bronchopulmonary Sequestration 17%
4. Caustics 51%
5. Chemoradiotherapy 22%
6. Drug Therapy 24%
7. Emphysema 20%
8. ErbB Receptors 42%
9. Esophageal Squamous Cell Carcinoma 26%
10. Esophagus 22%
11. Galactosyltransferases 81%
12. Heterografts 21%
13. Idiopathic Pulmonary Fibrosis 21%
14. Intensity-Modulated Radiotherapy 21%
15. Lung 76%
16. Lung Neoplasms 42%
17. Lymph Nodes 17%
18. Machine Learning 20%
19. Miniature Swine 32%
20. Mutation 17%
21. Neoplasms 52%
22. nintedanib 18%
23. Non-Small Cell Lung Carcinoma 68%
24. osimertinib 18%
25. Papio 65%
26. Protein-Tyrosine Kinases 40%
27. Pulmonary Tuberculosis 41%
28. Segmental Mastectomy 48%
29. Stomach 23%
30. Survival 56%
31. Swine 91%
32. Therapeutics 22%
33. Thoracotomy 17%
34. Thorax 27%
35. Thrombotic Microangiopathies 30%
36. Thymic epithelial tumor 67%
37. Thymoma 77%
38. Tomography 30%
39. Trachea 18%
40. Transplantation 17%
41. Transplants 29%
42. Video-Assisted Thoracic Surgery 100%
43. Wounds and Injuries 29%